×
About 105,198 results

ALLMedicine™ Immunodeficiency Center

Research & Reviews  51,069 results

Transcriptomics analysis of Toxoplasma gondii-infected mouse macrophages reveals coding...
https://doi.org/10.1186/s12864-021-07437-0 10.1128/CMR.05013-11 10.2741/Weiss 10.1007/s00281-012-0339-3 10.1093/intimm/dxy004 10.4049/jimmunol.164.10.5375 10.1371/journal.ppat.1003706 10.1016/j.immuni.2008.05.019 10.1016/j.coi.2010.04.008 10.4049/jimmunol.181.12.8485 10.4049/jimmunol.1501137 10.1182/blood-2005-02-0666 10.1016/j.chom.2019.09.008 10.1016/j.pt.2011.03.009 10.1016/j.chom.2012.12.003 10.4049/jimmunol.1301301 10.1126/science.1109893 10.1016/j.chom.2014.01.004 10.1126/science.1158298 10.1002/eji.201242683 10.1016/j.it.2019.04.001 10.3389/fcimb.2019.00132 10.1146/annurev-immunol-041015-055459 10.1038/ni.3771 10.1128/IAI.71.7.4171-4174.2003 10.4049/jimmunol.167.2.902 10.4049/jimmunol.167.8.4574 10.1371/journal.ppat.1002236 10.1016/j.chom.2011.04.015 10.4049/jimmunol.172.6.3686 10.1016/j.ijpara.2013.08.003 10.1016/j.micinf.2008.08.014 10.1038/s41467-018-06327-6 10.1038/s41434-018-0026-7 10.1038/s41419-018-0882-5 10.2147/CMAR.S208054 10.1186/1756-3305-6-356 10.1016/j.micpath.2018.05.030 10.3389/fcimb.2019.00309 10.1042/BJ20070170 10.1016/j.mib.2006.06.017 10.3389/fimmu.2019.01531 10.1371/journal.ppat.1003779 10.1371/journal.ppat.1008432 10.1186/1471-2164-15-806 10.1128/IAI.00439-13 10.1016/j.actatropica.2015.11.009 10.4049/jimmunol.167.2.902 10.4049/jimmunol.167.8.4574 10.1038/nature05395 10.1084/jem.20100717 10.1371/journal.ppat.1003051 10.1186/s13071-018-2697-8 10.3390/ncrna5040048 10.1038/s41598-018-33274-5 10.1016/j.coi.2013.12.001 10.4049/jimmunol.168.12.5997 10.1371/journal.pone.0111297 10.4049/jimmunol.172.5.3003 10.1093/nar/gky955 10.1093/bioinformatics/bts635 10.1093/bioinformatics/btt656 10.1093/bioinformatics/btt087 10.1186/gb-2004-5-10-r80 10.1007/978-3-319-24277-4 10.1371/journal.pone.0157022 10.1093/nar/gkz369
BMC Genomics; Menard KL, Bu L et. al.

Feb 24th, 2021 - Toxoplasma gondii is a globally distributed protozoan parasite that establishes life-long asymptomatic infection in humans, often emerging as a life-threatening opportunistic pathogen during immunodeficiency. As an intracellular microbe, Toxoplasm...

Strategies and progress in CXCR4-targeted anti-HIV therapeutic development.
https://doi.org/10.1093/cid/ciab160
Clinical Infectious Diseases : an Official Publication Of... Huang LSM, Snyder EY et. al.

Feb 24th, 2021 - The acquired immunodeficiency syndrome (AIDS), caused by the human immunodeficiency virus (HIV), has been a global public health challenge for several decades. The majority of HIV infection is caused by the human immunodeficiency virus type 1 (HIV...

TRIM28 Expression on Dendritic Cells Prevents Excessive T Cell Priming by Silencing End...
https://doi.org/10.4049/jimmunol.2001003
Journal of Immunology (Baltimore, Md. : 1950); Chikuma S, Yamanaka S et. al.

Feb 23rd, 2021 - Acquired immune reaction is initiated by dendritic cells (DCs), which present Ags to a few naive Ag-specific T cells. Deregulation of gene expression in DCs may alter the outcome of the immune response toward immunodeficiency and/or autoimmune dis...

Expression of Human Immunodeficiency Virus Transactivator of Transcription (HIV-Tat1-86...
https://doi.org/10.1007/s11481-021-09985-4 10.1096/fj.10-162313 10.1016/j.cyto.2014.11.001 10.1002/jnr.10762 10.1038/sj.jcbfm.9600115 10.1186/1743-422X-10-358 10.1002/ejp.1618 10.1016/0304-3959(88)90209-6 10.1177/1756285614564152 10.1371/journal.pone.0024412 10.1523/JNEUROSCI.3045-16.2017 10.3389/fphar.2019.00678 10.1016/j.neuron.2007.04.017 10.3389/fnmol.2017.00284 10.1016/j.neulet.2008.12.062 10.3389/fncel.2014.00302 10.1016/j.ejphar.2012.05.029 10.3791/51012 10.1007/s11904-007-0017-6 10.2174/1570159X11311050005 10.1097/QAD.0000000000002268 10.1136/bmj.324.7335.466 10.1073/pnas.1308673110 10.1021/jm500989n 10.1007/s13365-014-0236-8 10.1016/S0002-9440(10)64304-0 10.1248/bpb.32.651 10.1073/pnas.1009926107 10.1073/pnas.1009926107 10.1007/s13365-017-0598-9 10.1016/j.neulet.2016.12.073 10.1007/s13365-019-00757-8 10.1007/s11064-019-02824-2 10.1016/S1090-3801(02)00053-8 10.1016/S0006-8993(00)02050-3 10.1523/JNEUROSCI.21-08-02808.2001 10.18773/austprescr.2018.022 10.1097/j.pain.0000000000000171 10.1016/j.bbr.2015.05.021 10.1016/0091-3057(88)90243-2 10.1016/j.bbi.2019.03.011 10.1371/journal.pone.0014433 10.1016/j.pain.2014.06.014 10.1016/S1044-7431(03)00171-4 10.1016/j.brainres.2007.09.063 10.1093/infdis/jix013 10.1208/s12248-010-9191-3 10.1080/13550280701200102 10.1038/jcbfm.2011.197 10.1523/JNEUROSCI.2851-18.2019 10.1523/JNEUROSCI.3195-17.2018 10.1007/s11481-020-09951-6 10.1038/nn.4053 10.1002/glia.23768 10.1097/PR9.0000000000000654 10.1038/s41598-020-71073-z 10.1523/JNEUROSCI.5552-03.2004 10.1002/ana.24139
Journal of Neuroimmune Pharmacology : the Official Journa... Cirino TJ, Alleyne AR et. al.

Feb 23rd, 2021 - Despite the success of combined antiretroviral therapy (cART) in reducing viral load, a substantial portion of Human Immunodeficiency Virus (HIV)+ patients report chronic pain. The exact mechanism underlying this co-morbidity even with undetectabl...

Right ventricular load and contractility in HIV-associated pulmonary hypertension.
https://doi.org/10.1371/journal.pone.0243274
PloS One; Rajaratnam A, Rehman S et. al.

Feb 23rd, 2021 - People living with human immunodeficiency virus (PLWH) are at risk of developing pulmonary hypertension (PH) and right ventricular (RV) dysfunction, but understanding of the relationship of RV function to afterload (RV-PA coupling) is limited. We ...

see more →

Guidelines  145 results

Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recomm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147901
MMWR. Morbidity and Mortality Weekly Report; Tepper NK, Curtis KM et. al.

Apr 9th, 2020 - "U.S. Medical Eligibility Criteria for Contraceptive Use" (U.S. MEC) 2016 provides evidence-based guidance for the safe use of contraceptive methods among U.S. women with certain characteristics or medical conditions (1). The U.S. MEC is adapted f...

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
https://www.nejm.org/doi/full/10.1056/NEJMoa1909953
The New England Journal of Medicine; Tait,D.,et al

Oct 28th, 2019 - BACKGROUND Results of an earlier analysis of a trial of the M72/AS01E candidate vaccine against Mycobacterium tuberculosis showed that in infected adults, the vaccine provided 54.0% protection against active pulmonary tuberculosis disease, without...

Association between pubic hair grooming and prevalent sexually transmitted infection among female university students
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0221303
PLOS One; Luster,J.,et al

Sep 3rd, 2019 - Recent findings have suggested an association between pubic hair grooming and self-reported history of sexually transmitted infection (STI), specifically gonococcal infection (GC), chlamydial infection (CT), or human immunodeficiency virus (HIV). ...

Obesity Among HIV-Infected Adults Receiving Medical Care in the United States: Data From the Cross-Sectional Medical Monitoring Project and National Health and Nutrition Examination Survey
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504569/

Jul 12th, 2019 - Our objective was to compare obesity prevalence among human immunodeficiency virus (HIV)-infected adults receiving care and the U.S. general population and identify obesity correlates among HIV-infected men and women. Cross-sectional data was col...

HIV Infection and AIDS Differential Diagnoses
https://emedicine.medscape.com/article/211316-differential

Jun 30th, 2019 - Human immunodeficiency virus (HIV) infection should be considered in any patient with unusual or recurrent serious infections without another cause, especially in those with risk factors for HIV infection.

see more →

Drugs  663 results see all →

Clinicaltrials.gov  52,387 results

Transcriptomics analysis of Toxoplasma gondii-infected mouse macrophages reveals coding...
https://doi.org/10.1186/s12864-021-07437-0 10.1128/CMR.05013-11 10.2741/Weiss 10.1007/s00281-012-0339-3 10.1093/intimm/dxy004 10.4049/jimmunol.164.10.5375 10.1371/journal.ppat.1003706 10.1016/j.immuni.2008.05.019 10.1016/j.coi.2010.04.008 10.4049/jimmunol.181.12.8485 10.4049/jimmunol.1501137 10.1182/blood-2005-02-0666 10.1016/j.chom.2019.09.008 10.1016/j.pt.2011.03.009 10.1016/j.chom.2012.12.003 10.4049/jimmunol.1301301 10.1126/science.1109893 10.1016/j.chom.2014.01.004 10.1126/science.1158298 10.1002/eji.201242683 10.1016/j.it.2019.04.001 10.3389/fcimb.2019.00132 10.1146/annurev-immunol-041015-055459 10.1038/ni.3771 10.1128/IAI.71.7.4171-4174.2003 10.4049/jimmunol.167.2.902 10.4049/jimmunol.167.8.4574 10.1371/journal.ppat.1002236 10.1016/j.chom.2011.04.015 10.4049/jimmunol.172.6.3686 10.1016/j.ijpara.2013.08.003 10.1016/j.micinf.2008.08.014 10.1038/s41467-018-06327-6 10.1038/s41434-018-0026-7 10.1038/s41419-018-0882-5 10.2147/CMAR.S208054 10.1186/1756-3305-6-356 10.1016/j.micpath.2018.05.030 10.3389/fcimb.2019.00309 10.1042/BJ20070170 10.1016/j.mib.2006.06.017 10.3389/fimmu.2019.01531 10.1371/journal.ppat.1003779 10.1371/journal.ppat.1008432 10.1186/1471-2164-15-806 10.1128/IAI.00439-13 10.1016/j.actatropica.2015.11.009 10.4049/jimmunol.167.2.902 10.4049/jimmunol.167.8.4574 10.1038/nature05395 10.1084/jem.20100717 10.1371/journal.ppat.1003051 10.1186/s13071-018-2697-8 10.3390/ncrna5040048 10.1038/s41598-018-33274-5 10.1016/j.coi.2013.12.001 10.4049/jimmunol.168.12.5997 10.1371/journal.pone.0111297 10.4049/jimmunol.172.5.3003 10.1093/nar/gky955 10.1093/bioinformatics/bts635 10.1093/bioinformatics/btt656 10.1093/bioinformatics/btt087 10.1186/gb-2004-5-10-r80 10.1007/978-3-319-24277-4 10.1371/journal.pone.0157022 10.1093/nar/gkz369
BMC Genomics; Menard KL, Bu L et. al.

Feb 24th, 2021 - Toxoplasma gondii is a globally distributed protozoan parasite that establishes life-long asymptomatic infection in humans, often emerging as a life-threatening opportunistic pathogen during immunodeficiency. As an intracellular microbe, Toxoplasm...

Strategies and progress in CXCR4-targeted anti-HIV therapeutic development.
https://doi.org/10.1093/cid/ciab160
Clinical Infectious Diseases : an Official Publication Of... Huang LSM, Snyder EY et. al.

Feb 24th, 2021 - The acquired immunodeficiency syndrome (AIDS), caused by the human immunodeficiency virus (HIV), has been a global public health challenge for several decades. The majority of HIV infection is caused by the human immunodeficiency virus type 1 (HIV...

TRIM28 Expression on Dendritic Cells Prevents Excessive T Cell Priming by Silencing End...
https://doi.org/10.4049/jimmunol.2001003
Journal of Immunology (Baltimore, Md. : 1950); Chikuma S, Yamanaka S et. al.

Feb 23rd, 2021 - Acquired immune reaction is initiated by dendritic cells (DCs), which present Ags to a few naive Ag-specific T cells. Deregulation of gene expression in DCs may alter the outcome of the immune response toward immunodeficiency and/or autoimmune dis...

Expression of Human Immunodeficiency Virus Transactivator of Transcription (HIV-Tat1-86...
https://doi.org/10.1007/s11481-021-09985-4 10.1096/fj.10-162313 10.1016/j.cyto.2014.11.001 10.1002/jnr.10762 10.1038/sj.jcbfm.9600115 10.1186/1743-422X-10-358 10.1002/ejp.1618 10.1016/0304-3959(88)90209-6 10.1177/1756285614564152 10.1371/journal.pone.0024412 10.1523/JNEUROSCI.3045-16.2017 10.3389/fphar.2019.00678 10.1016/j.neuron.2007.04.017 10.3389/fnmol.2017.00284 10.1016/j.neulet.2008.12.062 10.3389/fncel.2014.00302 10.1016/j.ejphar.2012.05.029 10.3791/51012 10.1007/s11904-007-0017-6 10.2174/1570159X11311050005 10.1097/QAD.0000000000002268 10.1136/bmj.324.7335.466 10.1073/pnas.1308673110 10.1021/jm500989n 10.1007/s13365-014-0236-8 10.1016/S0002-9440(10)64304-0 10.1248/bpb.32.651 10.1073/pnas.1009926107 10.1073/pnas.1009926107 10.1007/s13365-017-0598-9 10.1016/j.neulet.2016.12.073 10.1007/s13365-019-00757-8 10.1007/s11064-019-02824-2 10.1016/S1090-3801(02)00053-8 10.1016/S0006-8993(00)02050-3 10.1523/JNEUROSCI.21-08-02808.2001 10.18773/austprescr.2018.022 10.1097/j.pain.0000000000000171 10.1016/j.bbr.2015.05.021 10.1016/0091-3057(88)90243-2 10.1016/j.bbi.2019.03.011 10.1371/journal.pone.0014433 10.1016/j.pain.2014.06.014 10.1016/S1044-7431(03)00171-4 10.1016/j.brainres.2007.09.063 10.1093/infdis/jix013 10.1208/s12248-010-9191-3 10.1080/13550280701200102 10.1038/jcbfm.2011.197 10.1523/JNEUROSCI.2851-18.2019 10.1523/JNEUROSCI.3195-17.2018 10.1007/s11481-020-09951-6 10.1038/nn.4053 10.1002/glia.23768 10.1097/PR9.0000000000000654 10.1038/s41598-020-71073-z 10.1523/JNEUROSCI.5552-03.2004 10.1002/ana.24139
Journal of Neuroimmune Pharmacology : the Official Journa... Cirino TJ, Alleyne AR et. al.

Feb 23rd, 2021 - Despite the success of combined antiretroviral therapy (cART) in reducing viral load, a substantial portion of Human Immunodeficiency Virus (HIV)+ patients report chronic pain. The exact mechanism underlying this co-morbidity even with undetectabl...

Right ventricular load and contractility in HIV-associated pulmonary hypertension.
https://doi.org/10.1371/journal.pone.0243274
PloS One; Rajaratnam A, Rehman S et. al.

Feb 23rd, 2021 - People living with human immunodeficiency virus (PLWH) are at risk of developing pulmonary hypertension (PH) and right ventricular (RV) dysfunction, but understanding of the relationship of RV function to afterload (RV-PA coupling) is limited. We ...

see more →

News  893 results

COVID-19 Outcomes in Patients With Immunodeficiency
https://www.medscape.com/viewarticle/943484

Jan 3rd, 2021 - Adults with primary immunodeficiency (PID) and symptomatic secondary immunodeficiency (SID) are at risk of greater morbidity and mortality from COVID-19 compared with the general population, a new study suggests. The findings were published in the...

Immunodeficiency Strongly Linked to Mental Illness, Suicidal Behavior
https://www.medscape.com/viewarticle/941482

Nov 22nd, 2020 - Patients with a primary humoral immunodeficiency (PID) are 91% more likely to have a psychiatric disorder and 84% more likely to exhibit suicidal behavior, compared against those without the condition, new research shows. Results showed that this ...

COVID-19 Outcomes Vary Widely in Patients With Primary Immunodeficiencies
https://www.staging.medscape.com/viewarticle/939374

Oct 19th, 2020 - NEW YORK (Reuters Health) - Clinical outcomes of COVID-19 in patients with primary immunodeficiency diseases range from mild illness to death, according to a small case series. "We were first surprised that we had only a few cases considering how ...

COVID-19 Outcomes Vary Widely in Patients With Primary Immunodeficiencies
https://www.medscape.com/viewarticle/939374

Oct 19th, 2020 - NEW YORK (Reuters Health) - Clinical outcomes of COVID-19 in patients with primary immunodeficiency diseases range from mild illness to death, according to a small case series. "We were first surprised that we had only a few cases considering how ...

Faltering AIDS Battle Risks 10-Year Setback From COVID-19, UN Warns
https://www.medscape.com/viewarticle/933434

Jul 6th, 2020 - LONDON (Reuters) - The global fight against AIDS was faltering even before the COVID-19 pandemic, and this newly-emerged viral disease is now threatening to put progress against HIV back by 10 years or more, the United Nations said on Monday. "The...

see more →

Patient Education  41 results see all →